Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
The only negative holding the sp down is the us covid situation and when us cinemas will open. Right now covid cases are going down and cinemas are slated to open in mid-august. As long as the covid cases dont go up or there is no delay in re-opening then the sp will re-rate higher in the next 2 weeks.
CINE have enough cash to last until the end of the year. As long as they open before then the future is good here
Tests are CE certified so can be sold in uk. Ive read somewhere that the UK gov have brought millions of tests from several companies. One of them could be BVC. The next rns will be a gamechanger.
from 25th june rns- Production and sales of both kits have been ramping up and the Group has shipped several hundred thousand test kits with a backlog of over a million orders still to be delivered.
AND
Finally, during the first half of 2020, the Group received an order of €29m (c. $31m) from a European government to provide 1,000 critical care ventilators to support their response to COVID-19. The Group has made significant progress towards completing the delivery of the contract on time.
Also from rns on 5th May-- The Adaltis Serological Tests are fully CE certified and the Group has commenced shipping initial orders to several customers in Europe. It is now ramping up production for larger quantities to fulfil further orders received from these customers.
They are already producing and selling millions of tests. More importantly they have 3 new tests that can potentially be sold to existing customers. They obviously have big customers that they have already sold to including european governments so they have an oppportunity to sell the new tests in large quantities as well.
This share price will hit £3 soon.
is unnerving watching the sp fall but this is not a share to be out of when news hits. They will soon begin production of 3 new tests in italy and have already seccured significant orders. This is from a news artcle a few daya ago
"The Group has expanded the gene discovery capability of its COVID-19 antigen test to five and, importantly, to include the spike (S) gene. The S gene is the protein that the virus uses to invade human cells. It is present in a person’s blood even if they have a very low viral load of COVID-19 (which might otherwise go undetected). As a result, by being able to detect the S gene, this test can provide more accurate results, reducing the risk of false positives and false negatives.
Reducing false negative results will prevent missing real cases, especially those in the early stages of infection, who could unknowingly spread the infection. At the same time, reducing false positive results will avoid the needless quarantining of people who have not actually been infected.
ELISA and CLIA antibody tests for SARS-CoV-2 perform best in terms of sensitivity
The five gene discovery capability compares with a market standard of one to three gene discovery capability. This kit can run on Adaltis instruments as well as on any standard PCR instrument."
Also
"The Group has launched a new molecular diagnostics kit that is able to test for multiple respiratory pathogens at the same time. In less than an hour, it can identify the particular cause (pathogen) of a respiratory illness, enabling the correct treatment or action to be rapidly implemented. It can identify and differentiate between all prominent respiratory viruses, including all strains of COVID-19, flu and the common cold. It can also detect the bacteria that cause the serious pulmonary illnesses that are believed to be a secondary infection of COVID-19, such as pneumonia and Legionnaires’ disease. This new kit was developed in collaboration with academics at Tor Vergata University in Italy.
The ability to rapidly identify the specific cause of a disease enables the correct treatment to be given more quickly resulting in better patient outcomes. This is particularly important for the coming winter where seasonal colds and flu could appear alongside COVID-19 and patients would present with similar symptoms, with cases already on the rise in parts of the southern hemisphere where winter has begun. The ability to rapidly diagnose the particular illness would help to alleviate some of the heavy strain on the public health systems."
AFAIK there are other covid tests out there but none test for 5 genes. Also the test for identifying if it is a flu, cold or covid will sell in big numbers at the start of winter. We know producton and sales will begin at the end og q3/start of q4. When news comes in saying they are shipping millions of tests then then it will be another massive re-rate.
Cost for regal card is $23.50 a month for all regal cinemas. This alone will generate free cash flow once US cinemas open. The sp will explode once we get to within a week of US opening
This will keep CINE ticking over in terms of generating cash until the next blockbuster that comes out. Demand for tickets for Unhinged is crazy. Every cinema has 3 showings of it today, and most are close to half full. Considering capacity is capped at 50% this means most shows are close to selling out. Cant ask for more in the current climate.
Ive sold out. This is the only share I was in profit so couldnt take the risk of losing it as had quite a bit here so have made a decent 3 figure profit. Still think the sp is grossly undervalued but for some reason this is not being reflected in the sp. Still wish the best for everyone here bu secretly am hoping for a re-entry in the 70's lol.
Should have held on. Sp already up 3.42%. Result are out this month and will be brilliant. It's onwards and upwards now.
Still 2 days left and already the halls are filling up. Best thing is there is lots of buying of the more expensive tickets like IMAX, 4DX, Superscreen and screen X. Depending on the location these tickets are approx £10-£20. Just a few of these tickets are equal to a full house on a normal 2d screen in monetary terms. The UK market is over the worst now and things can only get better from now. The only thing needed now is for the US cinemas to open and then its game on.
This should not have any bearing on CINE's sp. Frstly it doesnt apply to the blockbuster movies. It only applies to the smaller movies that normally fizzle out after 3 weeks anyway. Secondly its not normal VOD that Universal can release the movie on after 17 days that cost a few bucks. It is premium VOD that costs $20 per download not a few dollars.
This deal will end up being a dud for both AMC and Universal which is why CINE have rightly distanced themselves from today. The movie studios need the cinema to ensure they make their billions. There is no way streaming can make up for this. The current model is release the movie in the cinema and hope some of the movie goers enjoyed it so much they are happy too buy or stream the dvd later. Taking out cimema from this equation does not neccessarily mean the same movie goers will opt to stream instead. The cinema takings are the cake and the latter streaming is the cherry on top in regards to revenue. Taking the cake away does not turn the cherry into a cake. It just means the person will end up starving.
Unless I am missing something, the way I see it, the GCL just allows the governemt to impose restrictions on movement if needed without it going to parliament. Doesnt mention anything about forcing companies to sell products at cost. Plus its highly unlikely they will force a company that is manufacturing and exporting millions of coronavirus tests worldwide to do this at no profit. No goverment would do that as it would discourage further R&D in the future.
Absolute worst case scenario they may say sell in the domestic market at cost price but Israel is a small country with 9m people and and 50k cases. That is a drop in the ocean compared to the millions of tests that are being exported world-wide.
Interim results are due out in August and will be phenomenal. Minumum growth in revenue and profit will be 25% but may be higher. Current mcap does not reflect the growth BVC have had in the last 3 months. The sp should be close to £3 or more as this is a £1bn company.
"As a result of the considerable growth in the Bio-Medical division, which has more than offset any loss of revenues in the Networking & Cyber division, BATM now expects to report a substantial increase in FY 2020 revenues, at least 25% higher than FY 2019 and materially higher than market expectations. It also expects to report EBITDA significantly ahead of market expectations."
The current tree shake will not prevent the sp from hitting new heights in the next few weeks.
The interest ws only around $162M. The rest was lease interest which was moved from depreciation to finanical bit. If you look closely EBITDAX went from $1bn to $1.5bn as a result so this cancelled out the additonal interest expense. Bottom line is $3.6bn debt and around $200m per year interest on that
Demand for tickets is strong. We are 2 days away from 31st and already many shows have sold over 20 tickets which can only go up. The only issue is when the US cinemas will open as they have already delayed it twice so until the opening day is confirmed the sp will suffer. But this is still a business that can make money even in these times and the sp will eventually reflect this. Just need to have nreves of steel and wait it out
Pre Covid, free cash flow was well over $1bn a year, interest on bank loans was under $200M. Net debt was being reduced and around $500M a year was being paid out in dividends.
Even with reduced capacity CINE will easily be able to cover the interest payments just from 100% openings in UK and ROW and a fraction of the US market. Fair enough there is not enough going around for a dividend but no one is buying in for that. There is no issue of CINE defaulting on debt short term unless they remain closed until well into 2021 which is not going to happen
Indepthwins- I cant be bothered to explain it, its already been said by RS2002, do you even listen to what anyone else says or are you one of those people who think they have all the answers. Just a simple request from me and everyone else. You have said what you have wanted to say, so unless you have anythng new to add can you stop clogging up this board. It is getting beyond a joke now.
Grimrip44- Never try to get a rational explanation from someone who keeps repeating the same thing despite being called out on it. Just imagine having this sort of convrsation with someone face to face. You would either bang your head on the wall in frustration or end up taking a swing lol. Better to just ignore. The fact is what it is. Net debt is 3.6bn, a nobody on a BB forum cant change this
Just go on to Odeon and Showcase website, check for your local cinema or any random one that is open and see how many tickets have been sold for each show. That will show you there is no fear in the general public and that people will continue to go watch movies on the big screen....end of story
Ive got figure of 56,130 and 451 deaths for 26 July. Either way it is around 20% drop in cases over the last 2 week average and 50% drop in daily deaths over the same time peroid. As long as the trend continues going down then its all to play for. Back in June when the sp hit £1 the daily cases were under 30K but deaths were anything from 300-1000. So obviously its the daily cases number that will have an effect on the sp and this is looking like it will now go down as it has been on a plateau for the last 2 weeks.
This has been a rollercoaster ride for sure but the only way now is up.
This week will be the last week of uncertainty. From tomorrow we will be able to see how much demand there is in the UK market for Cineworld cinemas. Based on what Showcase and Odeon ticket sales are on old movies I think shareholders will be in for a pleasant surprise as there is strong demand for cinema even in the current climate.
Secondly the US situation is as bad as it can get. Daily cases are around 60-80k and have been around this number for the last 2 weeks so can only go down from this barring a catastrophe. There is still another 2 weeks to go until US cinemas open. At worst some of the key states may still be closed but even if half of CINE cinemas in the US are open for business by mid-aug, this along with UK and the ROW cinemas will be enough to push the sp up. The current sp is now way the correct value for CINE. Even running at half capacity the sp should be around £1.50.
on average a cinema needs to sell 16% each show to breakeven so even at 50% capacity there is still potential to generate positive cash flow and in the current climate that is all that is needed